title: Treatment of colorectal carcinoma in adolescents and young adults with surgery, 5-fluorouracil/leucovorin/interferon-alpha 2a and radiation therapy.
authors.affiliation: Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. charles.pratt@stjude.org
authors.forename: C B
authors.initials: CB
authors.lastname: Pratt
authors.forename: B N
authors.initials: BN
authors.lastname: Rao
authors.forename: T E
authors.initials: TE
authors.lastname: Merchant
authors.forename: A
authors.initials: A
authors.lastname: Shah
authors.forename: L
authors.initials: L
authors.lastname: Avery
authors.forename: A
authors.initials: A
authors.lastname: Cain
authors.forename: S
authors.initials: S
authors.lastname: Bodner
authors.forename: C
authors.initials: C
authors.lastname: Poquette
authors.forename: M
authors.initials: M
authors.lastname: Tan
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D002648:Child; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D011994:Recombinant Proteins; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D002955:Leucovorin; D005472:Fluorouracil